Literature DB >> 11890723

Expression of lumican in thickened intima and smooth muscle cells in human coronary atherosclerosis.

Munehiko Onda1, Toshiyuki Ishiwata, Kiyoko Kawahara, Ruojiao Wang, Zenya Naito, Yuichi Sugisaki.   

Abstract

Lumican is a member of a small leucine-rich proteoglycan family. Members of this family play an important role in cell migration and proliferation during embryonic development, tissue repair, and tumor growth. Lumican is reported to be overexpressed during the wound-healing process in the cornea and ischemic and reperfused heart. Recently, we found that lumican mRNA and its protein are expressed in cultured vascular smooth muscle cells (VSMCs) from the rat aorta. However, the expression and role of lumican in human atherosclerotic tissues are not clearly elucidated. In the present study, we aimed to clarify whether lumican is expressed in VSMCs and its localization in human coronary atherosclerotic tissues. The lumican protein and its mRNA were expressed in a small number of VSMCs in the media of normal coronary artery, but the lumican protein was not localized in the medial stroma. In contrast, the lumican protein and its mRNA were expressed in most of VSMCs that migrated into the thickened intima, but not in infiltrating foamy macrophages. The lumican protein was prominently localized in the thickened intimal stroma. The lumican protein and its mRNA were also expressed in VSMCs in the inner layer of the media and its protein was localized in medial stromal tissues. These findings indicate that the lumican protein is mainly synthesized by intimal and medial VSMCs in coronary atherosclerosis and that lumican contributes to collagen fibrillogenesis of coronary atherosclerosis. Copyright 2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11890723     DOI: 10.1006/exmp.2002.2425

Source DB:  PubMed          Journal:  Exp Mol Pathol        ISSN: 0014-4800            Impact factor:   3.362


  15 in total

Review 1.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 2.  Vascular extracellular matrix and arterial mechanics.

Authors:  Jessica E Wagenseil; Robert P Mecham
Journal:  Physiol Rev       Date:  2009-07       Impact factor: 37.312

Review 3.  The small leucine-rich repeat proteoglycans in tissue repair and atherosclerosis.

Authors:  A Hultgårdh-Nilsson; J Borén; S Chakravarti
Journal:  J Intern Med       Date:  2015-11       Impact factor: 8.989

4.  Electron-Transfer/Higher-Energy Collision Dissociation (EThcD)-Enabled Intact Glycopeptide/Glycoproteome Characterization.

Authors:  Qing Yu; Bowen Wang; Zhengwei Chen; Go Urabe; Matthew S Glover; Xudong Shi; Lian-Wang Guo; K Craig Kent; Lingjun Li
Journal:  J Am Soc Mass Spectrom       Date:  2017-07-10       Impact factor: 3.109

Review 5.  A role for proteoglycans in vascular disease.

Authors:  Thomas N Wight
Journal:  Matrix Biol       Date:  2018-02-27       Impact factor: 11.583

6.  Analysis of intimal proteoglycans in atherosclerosis-prone and atherosclerosis-resistant human arteries by mass spectrometry.

Authors:  Paul Talusan; Shahinaz Bedri; Suping Yang; Taj Kattapuram; Nilsa Silva; Peter J Roughley; James R Stone
Journal:  Mol Cell Proteomics       Date:  2005-06-21       Impact factor: 5.911

7.  Cholesterol in human atherosclerotic plaque is a marker for underlying disease state and plaque vulnerability.

Authors:  Zhu Chen; Marina Ichetovkin; Marc Kurtz; Emanuel Zycband; Douglas Kawka; John Woods; Xuanmin He; Andrew S Plump; Eric Hailman
Journal:  Lipids Health Dis       Date:  2010-06-11       Impact factor: 3.876

8.  Lumican, an extracellular matrix proteoglycan, is a novel requisite for hepatic fibrosis.

Authors:  Anuradha Krishnan; Xia Li; Winstonwhei-Yang Kao; Kimberly Viker; Kim Butters; Howard Masuoka; Bruce Knudsen; Gregory Gores; Michael Charlton
Journal:  Lab Invest       Date:  2012-09-24       Impact factor: 5.662

9.  Atherofibrosis - a unique and common process of the disease pathogenesis of atherosclerosis and fibrosis - lessons for biomarker development.

Authors:  Efstathios Vassiliadis; Natasha Barascuk; Morten A Karsdal
Journal:  Am J Transl Res       Date:  2013-01-21       Impact factor: 4.060

10.  Association of SLRPs with carotid artery atherosclerosis in essential hypertensive patients.

Authors:  Yan Yang; Qi-Hong Wu; Yan Li; Ping-Jin Gao
Journal:  J Hum Hypertens       Date:  2018-06-05       Impact factor: 3.012

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.